Related Experiment Video
Updated: Jan 14, 2026

Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice
Published on: December 4, 2020
Trichosporon Urinary Tract Infections: A Hidden Menace Revealed.
Ahmad Elmimoghaddam1, Mahmoud Vahidi1,2, Reza Heidari1,3
1Medical Biotechnology Research Center, AJA University of Medical Sciences, Tehran, Iran.
Urinary tract infections (UTIs) caused by Trichosporon species, particularly Trichosporon asahii, are a growing concern in immunocompromised patients. Voriconazole shows the best in vitro activity against these fungal UTIs.
Area of Science:
- Mycology
- Infectious Diseases
- Clinical Microbiology
Background:
- Urinary tract infections (UTIs) caused by fungi, specifically Trichosporon species, pose a significant threat to hospitalized individuals and those with compromised immune systems.
- Accurate identification and understanding of antifungal susceptibility are crucial for effective management.
Purpose of the Study:
- To provide a comprehensive review of Trichosporon-induced UTIs, covering epidemiology, risk factors, diagnostics, and drug resistance.
- To highlight the predominant species and serotype responsible for these infections and evaluate current treatment strategies.
Main Methods:
- A narrative review methodology was employed, involving a thorough search of international scientific databases.
- Relevant studies focusing on Trichosporon UTIs, their causative agents, risk factors, diagnostic methods, and antifungal susceptibility were analyzed.
Main Results:
- Trichosporon asahii, particularly the G1 type, is identified as the primary cause of Trichosporon UTIs.
- Prolonged hospitalization and immunosuppressive therapy are key risk factors.
- Voriconazole exhibits potent in vitro activity against T. asahii, whereas amphotericin B and echinocandins show limited efficacy.
Conclusions:
- Accurate identification of Trichosporon species, utilizing advanced techniques like MALDI-TOF MS and DNA sequencing, is vital for optimal patient care.
- Voriconazole is a promising therapeutic option for Trichosporon UTIs, necessitating further clinical investigation.
More Related Videos
Related Concept Videos
Urinary Tract Infection I: Introduction
Urinary Tract Infection II: Pathophysiology
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Infection IV: Nursing Management
Sexually Transmitted Infections
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

